DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,380,661 | +16.1% | 37,810 | +12.3% | 0.10% | +10.6% |
| Q2 2023 | $8,078,160 | -1.5% | 33,659 | +3.5% | 0.09% | -2.1% |
| Q1 2023 | $8,198,105 | -9.4% | 32,527 | -4.6% | 0.10% | -15.8% |
| Q4 2022 | $9,051,087 | +83.8% | 34,101 | +78.9% | 0.11% | +46.2% |
| Q3 2022 | $4,925,000 | +9.8% | 19,066 | +7.8% | 0.08% | -3.7% |
| Q2 2022 | $4,486,000 | -18.0% | 17,693 | -5.1% | 0.08% | +2.5% |
| Q1 2022 | $5,471,000 | +60.8% | 18,650 | +80.3% | 0.08% | +68.1% |
| Q4 2021 | $3,403,000 | +1341.9% | 10,342 | +1236.2% | 0.05% | +1466.7% |
| Q3 2021 | $236,000 | -99.3% | 774 | -99.4% | 0.00% | -99.0% |
| Q2 2021 | $32,016,000 | -64.9% | 119,303 | -70.6% | 0.30% | -53.0% |
| Q1 2021 | $91,197,000 | +0.1% | 405,178 | -1.2% | 0.63% | +30.6% |
| Q4 2020 | $91,111,000 | -14.2% | 410,153 | -16.9% | 0.48% | -8.5% |
| Q3 2020 | $106,222,000 | +8.6% | 493,300 | -10.8% | 0.53% | +12.3% |
| Q2 2020 | $97,840,000 | -1.1% | 553,300 | -22.6% | 0.47% | -10.6% |
| Q1 2020 | $98,942,000 | -43.1% | 714,850 | -36.9% | 0.53% | -28.1% |
| Q4 2019 | $173,962,000 | +9.0% | 1,133,453 | +2.5% | 0.73% | +56.0% |
| Q3 2019 | $159,644,000 | -1.5% | 1,105,353 | -2.5% | 0.47% | -5.2% |
| Q2 2019 | $162,109,000 | +29.0% | 1,134,257 | +19.2% | 0.50% | +9.7% |
| Q1 2019 | $125,625,000 | +13.1% | 951,559 | -11.6% | 0.45% | +1.1% |
| Q4 2018 | $111,027,000 | -12.8% | 1,076,681 | -8.1% | 0.45% | +8.8% |
| Q3 2018 | $127,355,000 | -1.4% | 1,172,059 | -10.4% | 0.41% | +1.7% |
| Q2 2018 | $129,102,000 | +22.5% | 1,308,283 | +21.6% | 0.40% | +22.8% |
| Q1 2018 | $105,349,000 | +7.8% | 1,075,983 | +2.2% | 0.33% | +10.4% |
| Q4 2017 | $97,744,000 | +7.3% | 1,053,045 | -0.9% | 0.30% | +3.8% |
| Q3 2017 | $91,111,000 | +7.0% | 1,062,145 | +5.2% | 0.29% | +2.9% |
| Q2 2017 | $85,176,000 | +26.4% | 1,009,309 | +28.1% | 0.28% | +23.5% |
| Q1 2017 | $67,398,000 | +7.6% | 788,009 | -2.1% | 0.23% | +2.7% |
| Q4 2016 | $62,656,000 | +8111.8% | 804,926 | +8176.0% | 0.22% | +7233.3% |
| Q3 2016 | $763,000 | +104.6% | 9,726 | +98.7% | 0.00% | +200.0% |
| Q2 2016 | $373,000 | -44.3% | 4,895 | -30.7% | 0.00% | -66.7% |
| Q1 2016 | $670,000 | -11.8% | 7,068 | -13.6% | 0.00% | 0.0% |
| Q4 2015 | $760,000 | +59.3% | 8,181 | +46.2% | 0.00% | +50.0% |
| Q3 2015 | $477,000 | -42.6% | 5,594 | -42.4% | 0.00% | -33.3% |
| Q2 2015 | $831,000 | +0.8% | 9,707 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $824,000 | +24.7% | 9,707 | +26.0% | 0.00% | +33.3% |
| Q4 2014 | $661,000 | +12.8% | 7,707 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $586,000 | -10.4% | 7,707 | -7.2% | 0.00% | -33.3% |
| Q2 2014 | $654,000 | +135.3% | 8,307 | +124.1% | 0.00% | +200.0% |
| Q1 2014 | $278,000 | -2.8% | 3,707 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $286,000 | -44.4% | 3,707 | -50.0% | 0.00% | 0.0% |
| Q3 2013 | $514,000 | +118.7% | 7,414 | +100.0% | 0.00% | 0.0% |
| Q2 2013 | $235,000 | – | 3,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |